Key takeaways
Acarbose and Levemir (insulin detemir) are both medications used to manage blood sugar levels in people with diabetes. Acarbose is specifically used for Type 2 diabetes, while Levemir is used for both Type 1 and Type 2 diabetes. Acarbose is an alpha-glucosidase inhibitor taken orally, and it works by slowing down the digestion of carbohydrates in your gut. Levemir, on the other hand, is a long-acting insulin injected under the skin, helping to lower blood sugar levels over a 24-hour period. Acarbose is available as a generic medication, whereas Levemir does not have a generic option. Common side effects of acarbose include gas and diarrhea, while Levemir can cause low blood sugar, headaches, and injection site reactions. Acarbose is less likely to cause hypoglycemia when used alone, but Levemir can increase the risk of low blood sugar, especially when combined with other diabetes medications.
